Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Kala Pharmaceuticals Inc. buy BiotechBee

Kala Pharmaceuticals Inc.
Start price
€5.11
21.07.25 / 70%
Target price
€8.00
27.06.27
Performance (%)
26.25%
Price
€5.71
01.08.25
Summary
This prediction is currently active. The prediction currently has a performance of 26.25%. This prediction currently runs until 27.06.27. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w
Kala Pharmaceuticals Inc. -0.436%
iShares Core DAX® -3.352%
iShares Nasdaq 100 -0.740%
iShares Nikkei 225® -1.885%
iShares S&P 500 -0.952%

According to BiotechBee what are the pros and cons of Kala Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Kala Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 26.25%
Target price 8.000
Change
Ends at 27.06.27

Buy mit Kursziel 8,0

BiotechBee 
0
Report Share
21.07.25

Stopped prediction by BiotechBee for Kala Pharmaceuticals Inc.

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.51
23.10.24
€6.50
28.02.27
5.26%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
23.10.24 80%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.24
08.09.24
€8.00
30.04.27
5.25%
23.10.24

Could be very worthwhile Investment >20% year
BiotechBee 
08.09.24 70%